Logo

CLX

The Clorox Company

CLX

The Clorox Company NYSE
$107.94 0.18% (+0.19)

Market Cap $13.17 B
52w High $171.37
52w Low $98.20
Dividend Yield 4.92%
P/E 16.95
Volume 962.33K
Outstanding Shares 121.98M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $1.429B $471M $80M 5.598% $0.65 $189M
Q4-2025 $1.988B $499M $332M 16.7% $2.7 $492M
Q3-2025 $1.668B $501M $186M 11.151% $1.51 $336M
Q2-2025 $1.686B $502M $193M 11.447% $1.56 $315M
Q1-2025 $1.762B $513M $99M 5.619% $0.8 $255M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $166M $5.528B $5.39B $-22M
Q4-2025 $167M $5.561B $5.079B $321M
Q3-2025 $226M $5.512B $5.322B $27M
Q2-2025 $290M $5.577B $5.456B $-41M
Q1-2025 $278M $5.497B $5.273B $60M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $82M $93M $-34M $-59M $-1M $57M
Q4-2025 $336M $294M $-76M $-279M $-59M $219M
Q3-2025 $191M $286M $-53M $-299M $-65M $233M
Q2-2025 $194M $180M $-54M $-109M $12M $127M
Q1-2025 $103M $221M $89M $-237M $75M $182M

Revenue by Products

Product Q2-2025Q3-2025Q4-2025Q1-2026
Health and Wellness
Health and Wellness
$630.00M $630.00M $740.00M $560.00M
Household
Household
$450.00M $470.00M $640.00M $360.00M
International
International
$270.00M $260.00M $270.00M $250.00M
Lifestyle
Lifestyle
$340.00M $310.00M $340.00M $240.00M

Five-Year Company Overview

Income Statement

Income Statement Sales have been broadly flat over the last several years, which suggests a mature, steady business rather than a high-growth story. The more important change is profitability: margins were squeezed in the middle of the period but have since recovered, and recent operating profit and earnings sit clearly above the earlier trough. This rebound points to better pricing, cost control, or mix, but it also highlights that earnings can be quite sensitive to swings in costs and demand. Overall, the income statement now looks healthier than a few years ago, but with a track record that includes a noticeable rough patch.


Balance Sheet

Balance Sheet The balance sheet shows a company that relies meaningfully on debt and has a relatively thin equity cushion, which points to a more leveraged profile. Total assets have gradually edged down, which can reflect portfolio pruning, lower investment, or past write-downs. Cash on hand is modest, so the company depends on ongoing cash generation and access to credit rather than a large cash war chest. Debt levels have been trimmed only slowly, so financial flexibility is adequate but not overly conservative, and balance sheet strength remains an area to watch.


Cash Flow

Cash Flow Cash generation is a key strength: the business consistently produces solid operating cash flow and free cash flow, even in tougher years. There was a dip in cash performance during the weaker profit period, but cash flows have since recovered in line with the margin improvement. Investment in the business through capital spending has been steady and manageable relative to the cash coming in. Taken together, the cash flow profile suggests a resilient, cash-generative franchise that can fund its operations, invest in growth, and service its debt, though not with huge excess slack.


Competitive Edge

Competitive Edge Clorox enjoys a strong competitive position built on very well-known brands, high consumer trust, and leading market shares in many of its categories. Its products are deeply embedded in household routines, giving it pricing power and resilience even when consumers are under pressure. A broad portfolio that spans cleaning, trash bags, water filtration, natural personal care, and charcoal helps smooth out category-specific ups and downs. Extensive retail relationships and distribution coverage are additional barriers for smaller rivals, though competition from other global consumer companies and retailer private labels remains a constant challenge.


Innovation and R&D

Innovation and R&D Innovation at Clorox is increasingly driven by data and technology rather than traditional slow-moving research cycles. The company’s “Digital Core” and use of AI to track consumer trends allow it to spot emerging needs quickly and translate them into products, such as new cleaning formats and more pleasant-scented lines. There is a clear focus on wellness and sustainability, with plant-based and eco-friendly offerings and brands like Burt’s Bees reinforcing that direction. Operational technology upgrades in manufacturing, and the broader IGNITE strategy, signal ongoing investment in efficiency and product evolution, though the long-term payoff will depend on consistent execution and the success of new launches.


Summary

Clorox today looks like a stable, mature consumer business that has navigated a period of margin pressure and emerged with healthier profitability and cash flow, even though top-line growth has been subdued. Its balance sheet carries meaningful leverage and only modest cash, which is mitigated but not eliminated by strong recurring cash generation. The company’s enduring strengths lie in its trusted brands, leading market positions, pricing power, and broad distribution, all reinforced by a growing capability in data-driven innovation and sustainability-focused products. Key things to monitor over time are its ability to keep margins firm in a competitive, inflation-prone environment, the pace of balance sheet strengthening, and how well its digital and ESG-oriented strategies translate into durable consumer demand and brand relevance.